Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Richardson

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Biomolecular Structure & Dynamics|December 20, 2023
Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approachAnuj Kumar, Mansi Dutt, Budheswar Dehury, et al.
Plos One|September 30, 2010
Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicityPornpun Vivithanaporn, Ferdinand Maingat, Liang-Tzung Lin, et al.
Cancers|January 7, 2021
Ursolic Acid and Its Nanoparticles Are Potentiators of Oncolytic Measles Virotherapy against Breast Cancer CellsChing-Hsuan Liu, Shu Hui Wong, Chen-Jei Tai, et al.
Journal of Virology|July 2, 2010
Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122Liang-Tzung Lin, Ryan S Noyce, Tram N Q Pham, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2003
RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cellsJoyce A Wilson, Sumedha Jayasena, Anastasia Khvorova, et al.
Nature Biotechnology|April 22, 2003
Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human liversEric C Hsu, Belinda Hsi, Masami Hirota-Tsuchihara, et al.
Nature Communications|June 3, 2020
Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAsJohn C Rose, Nicholas A Popp, Christopher D Richardson, et al.
BMC Microbiology|August 9, 2013
Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entryLiang-Tzung Lin, Ting-Ying Chen, Song-Chow Lin, et al.
Journal of Virology|September 15, 2017
Mutations in the Fusion Protein of Measles Virus That Confer Resistance to the Membrane Fusion Inhibitors Carbobenzoxy-d-Phe-l-Phe-Gly and 4-Nitro-2-Phenylacetyl Amino-BenzamideMichael N Ha, Sébastien Delpeut, Ryan S Noyce, et al.
Journal of Infection in Developing Countries|June 9, 2021
Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune responseAli Toloue Ostadgavahi, Ryan Booth, Gary Sisson, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Biomolecular Structure & Dynamics|December 20, 2023
Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approachAnuj Kumar, Mansi Dutt, Budheswar Dehury, et al.
Plos One|September 30, 2010
Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicityPornpun Vivithanaporn, Ferdinand Maingat, Liang-Tzung Lin, et al.
Cancers|January 7, 2021
Ursolic Acid and Its Nanoparticles Are Potentiators of Oncolytic Measles Virotherapy against Breast Cancer CellsChing-Hsuan Liu, Shu Hui Wong, Chen-Jei Tai, et al.
Journal of Virology|July 2, 2010
Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122Liang-Tzung Lin, Ryan S Noyce, Tram N Q Pham, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2003
RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cellsJoyce A Wilson, Sumedha Jayasena, Anastasia Khvorova, et al.
Nature Biotechnology|April 22, 2003
Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human liversEric C Hsu, Belinda Hsi, Masami Hirota-Tsuchihara, et al.
Nature Communications|June 3, 2020
Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAsJohn C Rose, Nicholas A Popp, Christopher D Richardson, et al.
BMC Microbiology|August 9, 2013
Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entryLiang-Tzung Lin, Ting-Ying Chen, Song-Chow Lin, et al.
Journal of Virology|September 15, 2017
Mutations in the Fusion Protein of Measles Virus That Confer Resistance to the Membrane Fusion Inhibitors Carbobenzoxy-d-Phe-l-Phe-Gly and 4-Nitro-2-Phenylacetyl Amino-BenzamideMichael N Ha, Sébastien Delpeut, Ryan S Noyce, et al.
Journal of Infection in Developing Countries|June 9, 2021
Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune responseAli Toloue Ostadgavahi, Ryan Booth, Gary Sisson, et al.
Pageof 5